Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo‐controlled clinical studies
Matthias Oelke; Adrian Wagg; Yasushi Takita; Hartwig Büttner; Lars Viktrup
Author Information: Department of Urology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.